TPE in Heparin-Induced Thrombocytopenia (HIT)

Purpose of this Study

We are doing this study is to understand how TPE (therapeutic plasma exchange) can help to decrease blood-clotting risk in patients.

Who Can Participate?

Eligibility

Adult ages 18+ who are receiving unfractionated heparin (UFH) or low molecular weight heparin (LMWH).

Age Range

18-99

Sex/Genders

Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No

What is Involved?

If you choose to join this study, you will:<ul>
<li>Participate in the study for about 30 days</li>
<li>Provide blood samples throughout the study</li></ul>

Locations

Duke University Hospital

Visit Timing

Weekdays
Weekends
Evenings

Compensation

No

Spanish Materials Available

No

Study Details

Full Title

Defining the Role of Therapeutic Plasma Exchange in Heparin Induced Thrombocytopenia

Principal Investigator

Oluwatoyosi
Onwuemene

Protocol Number

PRO00086436

Enrollment Status

Open to Enrollment